Published in Mediators Inflamm on December 30, 2014
Biomarkers for Sepsis: What Is and What Might Be? Biomark Insights (2015) 0.87
GROUP B STREPTOCOCCUS CIRCUMVENTS NEUTROPHILS AND NEUTROPHIL EXTRACELLULAR TRAPS DURING AMNIOTIC CAVITY INVASION AND PRETERM LABOR. Sci Immunol (2016) 0.85
Trends in the incidence of possible severe bacterial infection and case fatality rates in rural communities in Sub-Saharan Africa, South Asia and Latin America, 2010-2013: a multicenter prospective cohort study. Reprod Health (2016) 0.77
Comparative Assessment of Cytokine Pattern in Early and Late Onset of Neonatal Sepsis. J Immunol Res (2017) 0.77
Systems approach to the study of brain damage in the very preterm newborn. Front Syst Neurosci (2015) 0.76
IL-6 rs1800795 polymorphism is associated with septic shock-related death in patients who underwent major surgery: a preliminary retrospective study. Ann Intensive Care (2017) 0.75
The Impact of Venoarterial and Venovenous Extracorporeal Membrane Oxygenation on Cerebral Metabolism in the Newborn Brain. PLoS One (2016) 0.75
Surgical Neonatal Sepsis in Developing Countries. J Neonatal Surg (2015) 0.75
Comparison of the Functional microRNA Expression in Immune Cell Subsets of Neonates and Adults. Front Immunol (2016) 0.75
Inflammatory Response in Preterm and Very Preterm Newborns with Sepsis. Mediators Inflamm (2016) 0.75
Low Serum Angiopoietin-1, High Serum Angiopoietin-2, and High Ang-2/Ang-1 Protein Ratio are Associated with Early Onset Sepsis in Surinamese Newborns. Shock (2017) 0.75
Treatment with milk fat globule epidermal growth factor-factor 8 (MFG-E8) reduces inflammation and lung injury in neonatal sepsis. Surgery (2017) 0.75
Identification of potential biomarkers of sepsis using bioinformatics analysis. Exp Ther Med (2017) 0.75
The pathophysiology and treatment of sepsis. N Engl J Med (2003) 21.67
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med (1991) 16.81
IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol (2007) 14.99
International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med (2005) 13.40
The immunopathogenesis of sepsis. Nature (2002) 11.83
Role of transforming growth factor beta in human disease. N Engl J Med (2000) 10.17
The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA (1995) 9.54
Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet (1987) 7.24
The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med (1989) 6.99
High serum procalcitonin concentrations in patients with sepsis and infection. Lancet (1993) 6.67
The biology of interleukin-6. Blood (1989) 6.65
Interleukin 10 protects mice from lethal endotoxemia. J Exp Med (1993) 4.46
Increased plasma levels of interleukin-6 in sepsis. Blood (1989) 3.92
Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol (2004) 3.65
Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol (2007) 3.53
IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol (2009) 3.41
The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev (2008) 3.15
Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis (2000) 3.03
IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol (2007) 2.93
Sepsis: a new hypothesis for pathogenesis of the disease process. Chest (1997) 2.84
IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J Immunol (2008) 2.83
Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med (1990) 2.82
Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest (1993) 2.79
Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways. J Immunol (2005) 2.70
Adverse functions of IL-17A in experimental sepsis. FASEB J (2008) 2.60
Biological properties of interleukin 10. J Clin Immunol (1992) 2.50
Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol (2007) 2.46
IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol (2007) 2.43
Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res (2004) 2.38
IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J Immunol (2010) 2.29
IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci U S A (2007) 2.27
The global impact of neonatal infection. Clin Perinatol (1997) 1.99
Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol (1995) 1.94
Interleukin-10 controls the onset of irreversible septic shock. Infect Immun (2002) 1.76
The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol (2000) 1.74
Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Crit Care (2010) 1.67
Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants. Arch Dis Child Fetal Neonatal Ed (1997) 1.63
Evaluation of interleukin-6, tumour necrosis factor-alpha and interleukin-1beta for early diagnosis of neonatal sepsis. Acta Paediatr (1999) 1.63
Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view. Mediators Inflamm (2013) 1.54
Early-onset neonatal sepsis. Clin Microbiol Rev (2014) 1.53
Current trends in inflammatory and immunomodulatory mediators in sepsis. J Leukoc Biol (2012) 1.52
TGF-beta and regulatory T cell in immunity and autoimmunity. J Clin Immunol (2008) 1.49
Interleukin-6: a sensitive parameter for the early diagnosis of neonatal bacterial infection. Pediatrics (1994) 1.49
Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome. Crit Care (2009) 1.48
Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells. Eur J Biochem (1999) 1.48
Tumour necrosis factor in man: clinical and biological observations. Br J Cancer (1987) 1.46
The systemic pro-inflammatory response in sepsis. J Innate Immun (2010) 1.43
Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med (1999) 1.40
Transforming growth factor-beta. Multiple actions and potential clinical applications. JAMA (1989) 1.40
Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism. J Clin Oncol (1988) 1.37
Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed (2003) 1.30
High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J Infect Dis (1995) 1.28
Septic shock. Lancet (1998) 1.26
Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through gamma delta T-cell IL-17 production in a murine model of sepsis. Infect Immun (2010) 1.25
Differential patterns of 27 cord blood immune biomarkers across gestational age. Pediatrics (2009) 1.21
Soluble ST2 plasma concentrations predict mortality in severe sepsis. Intensive Care Med (2010) 1.19
Treating sepsis. N Engl J Med (2002) 1.18
What is the role of interleukin 10 in polymicrobial sepsis: anti-inflammatory agent or immunosuppressant? Surgery (1999) 1.17
Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study. Crit Care (2011) 1.09
Inhibition of interleukin-22 attenuates bacterial load and organ failure during acute polymicrobial sepsis. Infect Immun (2007) 1.06
Rapid diagnosis of sepsis. Virulence (2013) 1.06
Characterization of RAGE, HMGB1, and S100beta in inflammation-induced preterm birth and fetal tissue injury. Am J Pathol (2009) 1.05
Diagnostic value of plasma levels of tumor necrosis factor alpha (TNF alpha) and interleukin-6 (IL-6) in newborns with sepsis. Acta Paediatr (1994) 1.03
The value of cord blood interleukin-6 levels for predicting chorioamnionitis, funisitis and neonatal infection in term premature rupture of membranes. Eur J Obstet Gynecol Reprod Biol (2006) 1.03
Biomarkers for late-onset neonatal sepsis: cytokines and beyond. Clin Perinatol (2010) 1.01
Protective immunity and defects in the neonatal and elderly immune response to sepsis. J Immunol (2014) 1.01
Myocardial dysfunction in septic shock: Part II. Role of cytokines and nitric oxide. J Cardiothorac Vasc Anesth (2001) 0.99
The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation. Am J Obstet Gynecol (2007) 0.98
Anti-inflammatory cytokine response and the development of multiple organ failure in severe sepsis. Acta Anaesthesiol Scand (2003) 0.96
Bacterial endotoxin and current concepts in the diagnosis and treatment of endotoxaemia. J Med Microbiol (1990) 0.96
Endotoxin-stimulated production of rat hypothalamic interleukin-1 beta in vivo and in vitro, measured by specific immunoradiometric assay. J Mol Endocrinol (1993) 0.94
Differences between adult and pediatric septic shock. Minerva Anestesiol (2011) 0.94
Cord blood levels of cytokines as predictors of early neonatal sepsis. Acta Paediatr (2001) 0.93
Serum tumour necrosis factor in newborns at risk for infections. Eur J Pediatr (1990) 0.93
Gene transfer with IL-4 and IL-13 improves survival in lethal endotoxemia in the mouse and ameliorates peritoneal macrophages immune competence. Eur J Immunol (1998) 0.92
Sepsis: going to the heart of the matter. Pathobiology (2012) 0.92
IL-6 and TNFalpha across the umbilical circulation in term pregnancies: relationship with labour events. Early Hum Dev (2010) 0.92
Umbilical blood biomarkers for predicting early-onset neonatal sepsis. World J Pediatr (2012) 0.92
Thalidomide suppressed interleukin-6 but not tumor necrosis factor-alpha in volunteers with experimental endotoxemia. Transl Res (2007) 0.91
Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis. Lab Invest (1997) 0.91
New technologies for the rapid diagnosis of neonatal sepsis. Curr Opin Pediatr (2012) 0.90
[Cytokine storm in the pathogenesis of multiple organ dysfunction syndrome associated with surgical insults]. Nihon Geka Gakkai Zasshi (1996) 0.89
Interleukin-22 detected in patients with abdominal sepsis. Shock (2010) 0.89
Cell-associated interleukin-8 in cord blood of term and preterm infants. Clin Diagn Lab Immunol (2002) 0.89
The interleukin-4 expression in patients with severe sepsis. J Crit Care (2008) 0.88
Inflammatory mediators in umbilical plasma from neonates who develop early-onset sepsis. Biol Neonate (2001) 0.88
Comparative assessment of cytokines and other inflammatory markers for the early diagnosis of neonatal sepsis-a case control study. PLoS One (2013) 0.88
Immunosuppression after endotoxin shock: the result of multiple anti-inflammatory factors. J Trauma (1996) 0.87
Pediatric Sepsis - Part I: "Children are not small adults!" Open Inflamm J (2011) 0.87
Assessment of the contribution of cytokine plasma levels to detect retinopathy of prematurity in very low birth weight infants. Invest Ophthalmol Vis Sci (2011) 0.87
Endotoxin and tumor necrosis factor-alpha-induced interleukin-8 release in humans. J Infect Dis (1993) 0.86
Arrest of endotoxin-induced hypotension by transforming growth factor beta1. Proc Natl Acad Sci U S A (1996) 0.85
Transforming growth factor-beta 1 induces antigen-specific unresponsiveness in naive T cells. Immunol Invest (1997) 0.85
Prognostic value of MIP-1 alpha, TGF-beta 2, sELAM-1, and sVCAM-1 in patients with gram-positive sepsis. Clin Immunol Immunopathol (1998) 0.83
Reduced IL-10 production and -receptor expression in neonatal T lymphocytes. Acta Paediatr (2007) 0.83
Down-regulation of high mobility group-I(Y) protein contributes to the inhibition of nitric-oxide synthase 2 by transforming growth factor-beta1. J Biol Chem (2001) 0.83
Early-onset neonatal sepsis: cord blood cytokine levels at diagnosis and during treatment. J Pediatr (Rio J) (2010) 0.81